<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>制药合规 on Ops FreeEdge</title>
    <link>https://ops.freeedge.uk/tags/%E5%88%B6%E8%8D%AF%E5%90%88%E8%A7%84/</link>
    <description>Recent content in 制药合规 on Ops FreeEdge</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 03 Apr 2026 14:45:00 +0000</lastBuildDate>
    <atom:link href="https://ops.freeedge.uk/tags/%E5%88%B6%E8%8D%AF%E5%90%88%E8%A7%84/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>深度分析：面向药企客户的 Palo Alto 防火墙 AI 应用落地规划</title>
      <link>https://ops.freeedge.uk/posts/palo-alto-ai-analysis/</link>
      <pubDate>Fri, 03 Apr 2026 14:45:00 +0000</pubDate>
      <guid>https://ops.freeedge.uk/posts/palo-alto-ai-analysis/</guid>
      <description>&lt;p&gt;本文聚焦于以 Palo Alto Networks 的下一代防火墙体系为基础，探讨其 AI/ML 技术在制药行业的具体应用场景与合规影响。报告囊括了内联威胁预防、云交付安全服务、部署架构集成以及 OT 环境的零迷信安全落地建议。&lt;/p&gt;
&lt;br/&gt;
&lt;p&gt;👉 &lt;strong&gt;&lt;a href=&#34;https://ops.freeedge.uk/reports/palo-alto-ai-firewall.html&#34;&gt;点击查阅完整独立研报（包含实录架构图与评价矩阵）&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
